Tag: Acute Lymphoblastic Leukemia (ALL)

By Posted on Posted in New Drug Approval, Targeted Therapy, Thasso Post, Theragenomic Medicine Tagged with , , , , , , , , , , ,

August 18, 2017 – B-cell precursor acute lymphoblastic leukemia (ALL) is a aggressive and rapidly progressing type of cancer in which the bone marrow makes too many B-cell lymphocytes, an immature type of white blood cell. In the United States, …

Besponsa: Is this really a viable new treatment for ALL? Read more »

By Posted on Posted in Genetic Predisposition, Genetic Susceptibility, Personalized Medicine, Pharmacogenetics Tagged with , , , , ,

January 16, 2010 – This contribution has just been published in the ScienceBlog – Pharmacogenetics at this locoation. It is presented here in its original state and with all credentials and rights resting with the original author. Scientists at St. …

Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia (ALL) Read more »